Akiko Kobori

683 total citations
9 papers, 217 citations indexed

About

Akiko Kobori is a scholar working on Clinical Biochemistry, Neurology and Genetics. According to data from OpenAlex, Akiko Kobori has authored 9 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Biochemistry, 3 papers in Neurology and 3 papers in Genetics. Recurrent topics in Akiko Kobori's work include Advanced Glycation End Products research (4 papers), Alcoholism and Thiamine Deficiency (3 papers) and Diabetes and associated disorders (3 papers). Akiko Kobori is often cited by papers focused on Advanced Glycation End Products research (4 papers), Alcoholism and Thiamine Deficiency (3 papers) and Diabetes and associated disorders (3 papers). Akiko Kobori collaborates with scholars based in Japan. Akiko Kobori's co-authors include Makoto Arai, Mitsuhiro Miyashita, Masanari Itokawa, Kazuya Toriumi, Katsuto Hozumi, Yasue Horiuchi, Takehito Sato, Sonoko Habu, Takashi Nishimura and Naoji Amano and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and European Journal of Immunology.

In The Last Decade

Akiko Kobori

9 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akiko Kobori Japan	9	64	54	52	39	31	9	217
Anaïs Thouin United Kingdom	6	52 0.8×	108 2.0×	14 0.3×	70 1.8×	9 0.3×	7	281
Elżbieta Szmida Poland	14	8 0.1×	218 4.0×	23 0.4×	30 0.8×	53 1.7×	27	430
Alya Qari Saudi Arabia	8	56 0.9×	106 2.0×	6 0.1×	19 0.5×	4 0.1×	17	244
Stephanie N. Giamberardino United States	7	12 0.2×	97 1.8×	20 0.4×	25 0.6×	12 0.4×	14	171
Amber Lockridge United States	13	18 0.3×	180 3.3×	40 0.8×	42 1.1×	12 0.4×	19	334
Xiuyu Shi China	11	57 0.9×	185 3.4×	14 0.3×	56 1.4×	6 0.2×	23	310
Leonard E. Maroun United States	11	14 0.2×	212 3.9×	45 0.9×	94 2.4×	30 1.0×	20	414
Ambrin Fatima Pakistan	9	9 0.1×	149 2.8×	12 0.2×	16 0.4×	5 0.2×	33	254
Mark C. Hwang United States	10	6 0.1×	84 1.6×	88 1.7×	91 2.3×	8 0.3×	31	391
Theresa König Austria	9	8 0.1×	131 2.4×	20 0.4×	108 2.8×	4 0.1×	35	394

Countries citing papers authored by Akiko Kobori

Since Specialization

Citations

This map shows the geographic impact of Akiko Kobori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Kobori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Kobori more than expected).

Fields of papers citing papers by Akiko Kobori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Kobori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Kobori. The network helps show where Akiko Kobori may publish in the future.

Co-authorship network of co-authors of Akiko Kobori

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Kobori. A scholar is included among the top collaborators of Akiko Kobori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Kobori. Akiko Kobori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kobori, Akiko, Mitsuhiro Miyashita, Kazuhiro Suzuki, et al.. (2021). Advanced glycation end products and cognitive impairment in schizophrenia. PLoS ONE. 16(5). e0251283–e0251283. 9 indexed citations

Itokawa, Masanari, Mitsuhiro Miyashita, Makoto Arai, et al.. (2017). Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress. Psychiatry and Clinical Neurosciences. 72(1). 35–44. 39 indexed citations

Koike, Shin, Makoto Arai, Yasue Horiuchi, et al.. (2015). Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders. Biochemical and Biophysical Research Communications. 467(2). 361–366. 14 indexed citations

Arai, Makoto, Mitsuhiro Miyashita, Akiko Kobori, et al.. (2014). Carbonyl stress and schizophrenia. Psychiatry and Clinical Neurosciences. 68(9). 655–665. 29 indexed citations

Miyashita, Mitsuhiro, Makoto Arai, Akiko Kobori, et al.. (2013). Clinical Features of Schizophrenia With Enhanced Carbonyl Stress. Schizophrenia Bulletin. 40(5). 1040–1046. 46 indexed citations

Yeh, Christine J., et al.. (2001). Self and Coping Among College Students in Japan. Journal of college student development. 42(3). 17 indexed citations

Hozumi, Katsuto, Akiko Kobori, Takehito Sato, Takashi Nishimura, & Sonoko Habu. (1996). Transcription and demethylation of TCR β gene initiate prior to the gene rearrangement in c-kit⁺ thymocytes with CD3 expression: evidence of T cell commitment in the thymus. International Immunology. 8(10). 1473–1481. 22 indexed citations

Hozumi, Katsuto, Akiko Kobori, Takehito Sato, et al.. (1994). Pro‐T cells in fetal thymus express c‐kit and RAG‐2 but do not rearrange the gene encoding the T cell receptor β chain. European Journal of Immunology. 24(6). 1339–1344. 23 indexed citations

Hozumi, Katsuto, Motonari Kondo, Akiko Kobori, et al.. (1994). Implication of the common γ chain of the IL-7 receptor in intrathymic development of pro-T cells. International Immunology. 6(9). 1451–1454. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact